Ifosfamide-induced encephalopathy: Brand-name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®) - Université de Lorraine Access content directly
Journal Articles Journal of Clinical Pharmacy and Therapeutics Year : 2019

Ifosfamide-induced encephalopathy: Brand-name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®)

No file

Dates and versions

hal-02060140 , version 1 (07-03-2019)

Identifiers

Cite

Jeremy Chambord, Fabien Henny, Julia Salleron, Benoit Hombourger, Pauline Lider, et al.. Ifosfamide-induced encephalopathy: Brand-name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®). Journal of Clinical Pharmacy and Therapeutics, 2019, 44 (3), pp.372-380. ⟨10.1111/jcpt.12823⟩. ⟨hal-02060140⟩
44 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More